GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genflow Biosciences PLC (LSE:GENF) » Definitions » 1-Year ROIIC %

Genflow Biosciences (LSE:GENF) 1-Year ROIIC % : 154.86% (As of Jun. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Genflow Biosciences 1-Year ROIIC %?

1-Year Return on Invested Incremental Capital (1-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 1-year. Genflow Biosciences's 1-Year ROIIC % for the quarter that ended in Jun. 2024 was 154.86%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for Genflow Biosciences's 1-Year ROIIC % or its related term are showing as below:

LSE:GENF's 1-Year ROIIC % is ranked better than
80.79% of 1421 companies
in the Biotechnology industry
Industry Median: -11.22 vs LSE:GENF: 154.86

Genflow Biosciences 1-Year ROIIC % Historical Data

The historical data trend for Genflow Biosciences's 1-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genflow Biosciences 1-Year ROIIC % Chart

Genflow Biosciences Annual Data
Trend Dec21 Dec22 Dec23
1-Year ROIIC %
- 39,700.00 437.31

Genflow Biosciences Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
1-Year ROIIC % Get a 7-Day Free Trial - 39,700.00 - 437.31 154.86

Competitive Comparison of Genflow Biosciences's 1-Year ROIIC %

For the Biotechnology subindustry, Genflow Biosciences's 1-Year ROIIC %, along with its competitors' market caps and 1-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Genflow Biosciences's 1-Year ROIIC % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Genflow Biosciences's 1-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Genflow Biosciences's 1-Year ROIIC % falls into.



Genflow Biosciences 1-Year ROIIC % Calculation

Genflow Biosciences's 1-Year ROIIC % for the quarter that ended in Jun. 2024 is calculated as:

1-Year ROIIC %=1-Year Incremental Net Operating Profit After Taxes (NOPAT)**/1-Year Incremental Invested Capital
=( -1.531 (Jun. 2024) - -1.26 (Jun. 2023) )/( 0.036 (Jun. 2024) - 0.211 (Jun. 2023) )
=-0.271/-0.175
=154.86%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** TTM data of NOPAT and Invested Capital was used to calculate 1-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


Genflow Biosciences  (LSE:GENF) 1-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


Genflow Biosciences 1-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of Genflow Biosciences's 1-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Genflow Biosciences Business Description

Traded in Other Exchanges
Address
6 Heddon Street, London, GBR, W1B 4BT
Genflow Biosciences PLC is a preclinical biotechnology company focused on developing innovative biological interventions aimed at tackling the effects of aging, potentially slowing or halting the aging process and reducing the incidence of age-related diseases and thereby increasing life span. The company is also focused on longevity and the development of therapies to counteract the effects of aging and diseases associated with age.

Genflow Biosciences Headlines

No Headlines